THOC6
Basic information
Region (hg38): 16:3024027-3027755
Previous symbols: [ "WDR58" ]
Links
Phenotypes
GenCC
Source:
- THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome (Definitive), mode of inheritance: AR
- THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome (Strong), mode of inheritance: AR
- THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome (Supportive), mode of inheritance: AR
- THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome (Moderate), mode of inheritance: AR
- THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Beaulieu-Boycott-Innes syndrome | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Dental; Genitourinary; Neurologic; Renal | 23621916; 26739162; 27102954; 30476144 |
ClinVar
This is a list of variants' phenotypes submitted to
- THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome (3 variants)
- not provided (2 variants)
- Inborn genetic diseases (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the THOC6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 13 | ||||
missense | 27 | 32 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 1 | 2 | 1 | 4 | ||
non coding | 5 | |||||
Total | 5 | 10 | 30 | 14 | 3 |
Highest pathogenic variant AF is 0.00000657
Variants in THOC6
This is a list of pathogenic ClinVar variants found in the THOC6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-3024337-C-T | Inborn genetic diseases | Uncertain significance (Nov 10, 2022) | ||
16-3024342-C-T | Inborn genetic diseases | Uncertain significance (Oct 24, 2023) | ||
16-3024353-G-T | Likely benign (Jul 01, 2024) | |||
16-3024355-C-A | Inborn genetic diseases | Uncertain significance (Dec 07, 2023) | ||
16-3024360-G-A | Inborn genetic diseases | Uncertain significance (May 24, 2023) | ||
16-3025700-C-T | THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome | Benign (Sep 10, 2021) | ||
16-3025709-CAG-C | THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome | Likely pathogenic (Dec 28, 2019) | ||
16-3025714-G-A | Inborn genetic diseases | Uncertain significance (Oct 26, 2021) | ||
16-3025730-A-G | Inborn genetic diseases | Uncertain significance (Mar 25, 2024) | ||
16-3025761-C-T | Likely benign (Dec 31, 2019) | |||
16-3025803-C-A | THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome | Pathogenic/Likely pathogenic (Sep 23, 2024) | ||
16-3025804-G-A | THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome | Pathogenic (Apr 26, 2013) | ||
16-3025807-C-T | THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome | Pathogenic (Oct 23, 2020) | ||
16-3025824-G-T | THOC6-related disorder | Likely pathogenic (Mar 03, 2023) | ||
16-3025911-G-A | Uncertain significance (Jan 31, 2024) | |||
16-3025921-CA-C | THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome | Likely pathogenic (Oct 11, 2017) | ||
16-3025957-G-C | Inborn genetic diseases | Uncertain significance (Feb 13, 2024) | ||
16-3025974-T-C | Inborn genetic diseases | Uncertain significance (Jan 17, 2024) | ||
16-3025998-C-G | THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome | Benign (Sep 10, 2021) | ||
16-3026077-G-A | Inborn genetic diseases | Uncertain significance (Oct 05, 2021) | ||
16-3026079-C-T | THOC6-related disorder | Likely benign (Aug 14, 2019) | ||
16-3026097-C-T | Likely benign (Dec 01, 2023) | |||
16-3026101-C-T | Inborn genetic diseases • THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome | Pathogenic (Jan 09, 2015) | ||
16-3026140-T-A | Inborn genetic diseases • THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome | Pathogenic/Likely pathogenic (Jul 17, 2023) | ||
16-3026141-G-A | THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome | Likely pathogenic (-) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
THOC6 | protein_coding | protein_coding | ENST00000326266 | 13 | 3729 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000478 | 0.998 | 125714 | 0 | 34 | 125748 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.402 | 223 | 207 | 1.08 | 0.0000128 | 2189 |
Missense in Polyphen | 54 | 55.926 | 0.96557 | 646 | ||
Synonymous | -1.47 | 101 | 83.9 | 1.20 | 0.00000527 | 697 |
Loss of Function | 2.81 | 10 | 25.2 | 0.397 | 0.00000131 | 256 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000187 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000489 | 0.000489 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000489 | 0.000489 |
South Asian | 0.000132 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. Plays a role in apoptosis negative control involved in brain development. {ECO:0000269|PubMed:15833825, ECO:0000269|PubMed:15998806, ECO:0000269|PubMed:17190602, ECO:0000269|PubMed:18974867, ECO:0000269|PubMed:23621916}.;
- Disease
- DISEASE: Beaulieu-Boycott-Innes syndrome (BBIS) [MIM:613680]: An autosomal recessive neurodevelopmental disorder characterized by delayed development, moderate intellectual disability, and dysmorphic facial features. Other developmental anomalies, such as cardiac and renal defects, may also occur. {ECO:0000269|PubMed:23621916}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- RNA transport - Homo sapiens (human);Gene expression (Transcription);RNA Polymerase II Transcription;Metabolism of RNA;Cleavage of Growing Transcript in the Termination Region ;RNA Polymerase II Transcription Termination;Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3,-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.904
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.72
Haploinsufficiency Scores
- pHI
- 0.250
- hipred
- Y
- hipred_score
- 0.528
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.758
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Thoc6
- Phenotype
Gene ontology
- Biological process
- RNA export from nucleus;mRNA export from nucleus;apoptotic process;central nervous system development;RNA splicing;mRNA 3'-end processing;negative regulation of apoptotic process;viral mRNA export from host cell nucleus
- Cellular component
- transcription export complex;THO complex;THO complex part of transcription export complex;nuclear chromosome, telomeric region;nucleus;nucleoplasm;nuclear body;nuclear speck
- Molecular function
- RNA binding